Pleasanton, Calif. – – September 24, 2026 -- Aqua Medical, Inc. has closed a Series B financing round led by Nashville-based Relevance Ventures, with proceeds earmarked to complete its ongoing U.S. RESTORE-1 pilot study and prepare for a planned U.S. pivotal trial of its investigational diabetes procedure.